Effect of Cryptotanshinone on BDNF/TrkB Pathway in Hippocampus of Chronic Stress-induced Depression Rats

ABSTRACT

Background: Cryptotanshinone (CTS) is a monomer possessing a diverse array of pharmacological properties, primarily derived from Salvia miltiorrhiza. CTS was examined for its impact on rats with depression subjected to chronic unpredictable mild stress (CUMS) in this study. Materials and Methods: Depression-like behavior of rats was established by isolated feeding combined with CUMS for 28 days, with CTS (7/14/21 mg/kg) or fluoxetine (5 mg/kg) administered once daily during this time. A comprehensive evaluation was performed, including body weight assessment, sucrose preference test, forced swimming test, and open field test. Hematoxylin-eosin staining was conducted to detect pathological changes in hippocampal CA1 neurons. Western blot analysis was employed to assess the brain-derived neurotrophic factor (BDNF), tyrosine kinase receptor B (TrkB), Rasrelated C3 botulinum toxin substrate 1 (Rac1), and Cofilin expression levels in the hippocampus. Results: The depression rat model was successfully constructed. CTS can significantly improve impaired neurons in the hippocampal CA1 area, depression-like behaviors, and weight loss in CUMS-induced rats. Moreover, CTS reversed the down-regulation of BDNF/TrkB and Rac1/Cofilin in the CUMS-induced rats’ hippocampus. Conclusion: CTS demonstrates the therapeutic potential for depression by improving depression-like behaviors and ameliorating impaired neurons in the hippocampal CA1 area, and the mechanisms may involve the up-regulation of BDNF/ TrkB and related signaling proteins Rac1/Cofilin.

KEYWORDS

• Depression
• cryptotanshinone
• chronic unpredictable mild stress
• hippocampus
• BDNF
• TrkB

Showing references and in-text citations exactly as published.

• DOI10.1177/09731296241236034Copy

RELATED ARTICLES

Matched on section and article type within this issue of Pharmacogn. Mag..

• Article · VOLUME 20, ISSUE 3The Beneficial Effects of Topical Cream Containing 17% of Herbal Extract on Skin Barrier Function: A Randomized Four-week TrialJi-Hyo Lyu, Soyeon Kim, Kang Kwon, Yongkuk Kim, Chanhun Choi, Hyunwoo Jeong, Hyungwoo Kim · pp. 1005–1012Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 3Study on the Mechanism of Anti-atopic Dermatitis by Herba Siegesbeckiae Based on System PharmacologyXiaowei Chen, YingYue Wang, Xin Zhang, Chang Liu, Chunxue You, Yubin Xu · pp. 1013–1022Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 3Assessment of Immunomodulatory Activity of AP-Bio® (KalmCold®), a Standardized Extract of Andrographis paniculata Using in vivo and ex vivo ModelsNehru Sai Suresh Chalichem, Prathiksha Nabhan, Bharathi Bethapudi, Nikita Agarwal, Sasi Kumar Murugan, Mundkinajeddu Deepak · pp. 727–732Original Research ArticleSame type: Article
• Article · VOLUME 20, ISSUE 3Induction and Characterization of Tetraploids from Astragalus membranaceus (Fisch.) Bge. SeedsShu-ling Zhang, Xin Zhang, Meng Wang, Li-jun Dong, Gui-xia Liu · pp. 733–744Original Research ArticleSame type: Article